Results from a series of trials on four drugs to treat Alzheimer’s appear to bring a new era of hope to patients with the disease.

The four drugs are an anti-amyloid (Alzhemed), an inhibitor of brain cell death (Dimebon), an “Alzheimer’s vaccine” (Immunotherapy Treatment AN1792), and a drug normally used to treat diabetes (Avandia).